US Archives - Page 79 of 112 - European Medical Journal

Eosinophilic Inflammation in Focus: New Trial Data

Benralizumab, a monoclonal antibody targeting eosinophilic inflammation, outperformed prednisolone alone in treating acute exacerbations of asthma and COPD in a new study.

Farming Lessons to Combat Cancer Resistance

Agricultural pest management methods were explored in a new study to determine how they can be adapted to combat cancer treatment resistance.

Early Psychosis Detection In 5-Minute Scan

A functional brain biomarker that could revolutionize psychosis detection has been identified in a new study.

Cigarette Smoke Disrupts Microbiota, Worsens Flu Severity

Chronic exposure to cigarette smoke (CS) may significantly worsen the severity of influenza A virus (IAV) infections, not only through direct lung damage but also via changes in the microbiota.

Women with PsA Experience Longer Time to Diagnosis than Men

Women with psoriatic arthritis (PsA) experience longer delays in diagnosis, more intense symptoms, and distinct challenges with treatment compared to men, according to findings presented by Lihi Eder at ACR Convergence 2024.

Nutrient-Starved Tumors Resist Chemotherapy Damage

Glucose restriction in the tumor microenvironment helps cancer cells survive chemotherapy by altering key metabolic pathways, reveals a new study.

Real-World Data Sheds Light on Alzheimer’s Biomarker Strategies

Accurately diagnosing Alzheimer’s disease (AD) may soon become more efficient, thanks to a novel biomarker assessment strategy leveraging cerebrospinal fluid (CSF) and PET imaging data, according to a 10-year study conducted at university memory clinics in Europe.

Cystic Fibrosis Diabetes Linked to Protein Deficiency

Impaired insulin secretion in cystic fibrosis-related diabetes (CFRD) is driven by reduced expression of the GLP-1 receptor (GLP-1R) in pancreatic islet cells, according to the results of a new study.

New Trial in HIV Prevention With Lenacapavir

Twice-yearly lenacapavir injections have shown remarkable efficacy in preventing HIV infection, offering a promising alternative to daily oral PrEP for males and gender-diverse individuals.

Key Player in Melanoma Progression Identified

A new study has revealed how the protein Rab7a enhances the activity of TPC2, a cellular channel linked to melanoma, the deadliest form of skin cancer.